Wang Li, Li Xiaoguang, Wang Zhaoxin, Bancks Michael P, Carnethon Mercedes R, Greenland Philip, Feng Ying-Qing, Wang Hui, Zhong Victor W
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina.
JAMA. 2021 Jun 25;326(8):1-13. doi: 10.1001/jama.2021.9883.
Understanding population-wide trends in prevalence and control of diabetes is critical to planning public health approaches for prevention and management of the disease.
To determine trends in prevalence of diabetes and control of risk factors in diabetes among US adults between 1999-2000 and 2017-2018.
DESIGN, SETTING, AND PARTICIPANTS: Ten cycles of cross-sectional National Health and Nutrition Examination Survey (NHANES) data between 1999-2000 and 2017-2018 were included. The study samples were weighted to be representative of the noninstitutionalized civilian resident US population. Adults aged 18 years or older were included, except pregnant women.
Survey cycle.
Diabetes was defined by self-report of diabetes diagnosis, fasting plasma glucose level of 126 mg/dL or more, or hemoglobin A1c (HbA1c) level of 6.5% or more. Three risk factor control goals were individualized HbA1c targets, blood pressure less than 130/80 mm Hg, and low-density lipoprotein cholesterol level less than 100 mg/dL. Prevalence of diabetes and proportion of adults with diagnosed diabetes who achieved risk factor control goals, overall and by sociodemographic variables, were estimated.
Among the 28 143 participants included (weighted mean age, 48.2 years; 49.3% men), the estimated age-standardized prevalence of diabetes increased significantly from 9.8% (95% CI, 8.6%-11.1%) in 1999-2000 to 14.3% (95% CI, 12.9%-15.8%) in 2017-2018 (P for trend < .001). From 1999-2002 to 2015-2018, the estimated age-standardized proportion of adults with diagnosed diabetes who achieved blood pressure less than 130/80 mm Hg (P for trend = .007) and low-density lipoprotein cholesterol level less than 100 mg/dL (P for trend < .001) increased significantly, but not individualized HbA1c targets (P for trend = .51). In 2015-2018, 66.8% (95% CI, 63.2%-70.4%), 48.2% (95% CI, 44.6%-51.8%), and 59.7% (95% CI, 54.2%-65.2%) of adults with diagnosed diabetes achieved individualized HbA1c targets, blood pressure less than 130/80 mm Hg, and low-density lipoprotein cholesterol level less than 100 mg/dL, respectively. Only 21.2% of these adults (95% CI, 15.5%-26.8%) achieved all 3. During the entire study period, these 3 goals were significantly less likely to be achieved among young adults aged 18 to 44 years (vs older adults ≥65 years: estimated proportion, 7.4% vs 21.7%; adjusted odds ratio, 0.32 [95% CI, 0.16-0.63]), non-Hispanic Black adults (vs non-Hispanic White adults: estimated age-standardized proportion, 12.5% vs 20.6%; adjusted odds ratio, 0.60 [95% CI, 0.40-0.90]), and Mexican American adults (vs non-Hispanic White adults: estimated age-standardized proportion, 10.9% vs 20.6%; adjusted odds ratio, 0.48 [95% CI, 0.31-0.77]).
Based on NHANES data from US adults, the estimated prevalence of diabetes increased significantly between 1999-2000 and 2017-2018. Only an estimated 21% of adults with diagnosed diabetes achieved all 3 risk factor control goals in 2015-2018.
了解全人群糖尿病患病率及控制情况的趋势对于规划该疾病的预防和管理公共卫生方法至关重要。
确定1999 - 2000年至2017 - 2018年美国成年人中糖尿病患病率及糖尿病危险因素控制情况的趋势。
设计、背景和参与者:纳入了1999 - 2000年至2017 - 2018年期间十个周期的横断面国家健康与营养检查调查(NHANES)数据。研究样本经过加权处理,以代表美国非机构化平民居民人口。纳入18岁及以上成年人,孕妇除外。
调查周期。
糖尿病通过糖尿病诊断的自我报告、空腹血糖水平126mg/dL及以上或糖化血红蛋白(HbA1c)水平6.5%及以上来定义。三个危险因素控制目标分别为个体化HbA1c目标、血压低于130/80mmHg以及低密度脂蛋白胆固醇水平低于100mg/dL。估计糖尿病患病率以及已诊断糖尿病成年人实现危险因素控制目标的比例,总体情况以及按社会人口学变量分类的情况。
在纳入的28143名参与者中(加权平均年龄48.2岁;男性占49.3%),估计的年龄标准化糖尿病患病率从1999 - 2000年的9.8%(95%CI,8.6% - 11.1%)显著增加至2017 - 2018年的14.3%(95%CI,12.9% - 15.8%)(趋势P值<0.001)。从1999 - 2002年到2015 - 2018年,已诊断糖尿病成年人中实现血压低于130/80mmHg(趋势P值 = 0.007)和低密度脂蛋白胆固醇水平低于100mg/dL(趋势P值<0.001)的估计年龄标准化比例显著增加,但个体化HbA1c目标未增加(趋势P值 = 0.51)。在2015 - 2018年,已诊断糖尿病的成年人中分别有66.8%(95%CI,63.2% - 70.4%)、48.2%(95%CI,44.6% - 51.8%)和59.7%(95%CI,54.2% - 65.2%)实现了个体化HbA1c目标、血压低于130/80mmHg以及低密度脂蛋白胆固醇水平低于100mg/dL。这些成年人中只有21.2%(95%CI,15.5% - 26.8%)实现了所有三个目标。在整个研究期间,18至44岁的年轻成年人(与≥65岁的老年人相比:估计比例,7.4%对21.7%;调整后的优势比,0.32[95%CI,0.16 - 0.63])、非西班牙裔黑人成年人(与非西班牙裔白人成年人相比:估计年龄标准化比例,12.5%对20.6%;调整后的优势比,0.60[95%CI,0.40 - 0.90])以及墨西哥裔美国成年人(与非西班牙裔白人成年人相比:估计年龄标准化比例,10.9%对20.6%;调整后的优势比,0.48[95%CI,0.31 - 0.77])实现这三个目标的可能性显著更低。
基于美国成年人的NHANES数据,1999 - 2000年至2017 - 2018年期间糖尿病估计患病率显著增加。在2015 - 2018年,估计只有21%的已诊断糖尿病成年人实现了所有三个危险因素控制目标。